The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced around $1.7M in planned project activities via the Global Health Fund of the Institute Project Call6.1G for three new projects.
Also Read,
These three projects have been designed to...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) launches NIIMBL bioLOGIC, a pilot program designed to bring awareness to and foster interest in careers in the biopharmaceutical manufacturing industry. NIIMBL has partnered with the North Carolina Biotechnology Center and has selected Southern High School of Energy...
The Delaware Business Times is excited to announce the 2022 honorees of its second annual CEO of the Year program.
The awards program honors the efforts of Delaware’s top-ranking business leaders in both for-profit and nonprofit sectors. The winners, chosen by an independent judging panel, will be honored at a July 14 charity golf outing, dinner...
Some of the images from the first weeks of the COVID-19 pandemic are indelible: doctors and nurses wearing garbage bags instead of gowns and reusing the same protective mask for days at a time; homemade plastic face shields replacing professional-grade models; live coverage of deliveries of personal protective equipment to hard-hit hospitals. The...
The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease. While there are approximately 7,000 rare diseases, only two heritable diseases currently have FDA...
